Accéder au contenu
Merck

(Z)-3-(4-bromophenyl)-3-(3-pyridyl)allylamine as substrate for studies of myeloperoxidase activity.

Chemico-biological interactions (1995-02-01)
S Lindvall, G Rydell, L Johansson, B E Svensson, B Ulff
RÉSUMÉ

(Z)-3-(4-Bromophenyl)-3-(3-pyridyl)allylamine (CPP 200) is transformed to the corresponding chloroimine by hypochlorite ion (ClO-) formed in the presence of myeloperoxidase. A scheme for this transformation is given. The influence of various compounds on this process has been studied. Cysteamine, cysteine and 6-chloro-3-hydrazino-pyridazine inhibited the transformation of CPP 200, while some p-hydroxyphenyl derivatives increased the rate of transformation of CPP 200. The increase seen on addition of the p-hydroxyphenyl derivatives is not a chloride-dependent reaction. Various mechanisms for the inhibiting effect as well as for the activating effect on the transformation of CPP 200 are discussed.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3-(4-Hydroxyphenyl)propionic acid, 98%
Sigma-Aldrich
3-Chloro-6-hydrazinopyridazine, 97%